Other Species / Isoforms
  IFITM3 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T10
HTSQAFITAASGGQP
0 4
IFITM3 (human) HTVQTFFsPVNSGQP S10-p
IFITM3 (mouse) HTSQAFITAASGGQP T10
IFITM3 (rat) HTSQAFVNAATGGQP N10
Y20-p
SGGQPPNyERIkEEy
Upstream
Downstream
5 28
Effects on Modified Protein
  • intracellular localization
  • ubiquitination
Effects on Biological Processes:
  • endocytosis, inhibited
Putative in vivo kinases:
  • Fyn (human)
IFITM3 (human) NSGQPPNyEMLkEEH Y20-p
IFITM3 (mouse) SGGQPPNyERIkEEy Y20-p
IFITM3 (rat) TGGQPPNYERIKEEy Y20
K24-ub
PPNyERIkEEyEVAE
0 14
IFITM3 (human) PPNyEMLkEEHEVAV K24-ub
IFITM3 (mouse) PPNyERIkEEyEVAE K24-ub
IFITM3 (rat) PPNYERIKEEyEVSE K24
Y27-p
yERIkEEyEVAEMGA
Upstream
1 146
Putative in vivo kinases:
  • Fyn (human)
Treatment
  • IL-33
IFITM3 (human) yEMLkEEHEVAVLGA H27
IFITM3 (mouse) yERIkEEyEVAEMGA Y27-p
IFITM3 (rat) YERIKEEyEVSELGA Y27-p
S38-p
EMGAPHGsAsVRTTV
0 3
IFITM3 (human) VLGAPHNPAPPtSTV P38
IFITM3 (mouse) EMGAPHGsAsVRTTV S38-p
IFITM3 (rat) ELGAPHGSASVRTTV S38
S40-p
GAPHGsAsVRTTVIN
0 2
IFITM3 (human) GAPHNPAPPtSTVIH P40
IFITM3 (mouse) GAPHGsAsVRTTVIN S40-p
IFITM3 (rat) GAPHGSASVRTTVIN S40
R42
PHGsAsVRTTVINMP
0 1
IFITM3 (human) PHNPAPPtSTVIHIR T42-p
IFITM3 (mouse) PHGsAsVRTTVINMP R42
IFITM3 (rat) PHGSASVRTTVINMP R42
V52
VINMPREVSVPDHVV
0 1
IFITM3 (human) VIHIRSEtSVPDHVV T52-p
IFITM3 (mouse) VINMPREVSVPDHVV V52
IFITM3 (rat) VINMPREVSVPDHVV V52
K88-ub
SVKSRDRkMVGDVTG
0 9
IFITM3 (human) SVKSRDRkMVGDVTG K88-ub
IFITM3 (mouse) SVKSRDRkMVGDVTG K88-ub
IFITM3 (rat) SVKSRDRKMVGDMTG K88
Y99-p
DVTGAQAyASTAKCL
1 5
IFITM3 (human) DVTGAQAyASTAKCL Y99-p
IFITM3 (mouse) DVTGAQAyASTAKCL Y99-p
IFITM3 (rat) DMTGAQAYASTAKCL Y99